A Study for Patients With Multiple Sclerosis

Clinical trial NCT00870155 · TERMINATED

Trial details

NCT number: NCT00870155
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Secondary Progressive Multiple Sclerosis

Start date: 2007-02-01
Primary completion: 2009-09-01
Enrollment: 546

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.